Rising demand for controlled fluid drainage and growing interest in outpatient care are shaping opportunities for ascites management technologies, according to Fact.MR.

NEWARK, Del., October 13, 2026. The global ascites fluid removal devices market is projected to increase from USD 0.78 billion in 2026 to USD 1.77 billion by 2036, expanding at a compound annual growth rate (CAGR) of 8.5%, according to Fact.MR. The market is expected to generate an additional USD 0.99 billion in revenue over the forecast period as healthcare providers respond to the growing burden of advanced liver disease and cancer-related fluid accumulation.

Demand is shifting toward systems that offer controlled drainage, integrated monitoring and more flexible approaches to managing recurrent ascites. Automated paracentesis systems already account for the largest device-type segment, while hospitals remain the principal end users. The report also identifies opportunities for closed-loop systems that support home-based and ambulatory care.

Get detailed market forecasts, competitive benchmarking, and pricing trends:

What Is Driving Demand for Ascites Fluid Removal Devices?

The growing prevalence of chronic liver disease is a central demand driver. Fact.MR identifies metabolic dysfunction-associated steatotic liver disease, liver cirrhosis and cancer-associated ascites as important factors influencing the need for fluid removal procedures.

Healthcare providers are also focusing on fluid management strategies that can reduce avoidable hospital readmissions. Advances in controlled flow rates and integrated monitoring are supporting interest in automated drainage technologies, while the expansion of outpatient and home-based care is creating demand for devices suited to different treatment settings.

The report identifies remote monitoring and telehealth integration as emerging market trends. These capabilities could allow clinicians to monitor fluid status and device performance outside traditional hospital settings, subject to clinical requirements and the suitability of individual patients.

Where Growth Is Fastest

Fact.MR projects growth across five profiled country markets between 2026 and 2036:

India — 12.3% CAGR: Expanding healthcare infrastructure, increased diagnosis of liver disease and investment in advanced hepatology services are supporting demand. The market also presents opportunities for manual and basic automated drainage kits across different healthcare settings.
China — 12.1% CAGR: Greater attention to chronic liver disease management and the expansion of hepatology and interventional radiology departments are supporting adoption. Development of more affordable paracentesis systems may broaden access across mid-tier hospitals.
United States — 11.0% CAGR: Established healthcare infrastructure, adoption of advanced medical devices and an emphasis on reducing preventable hospital readmissions are supporting market growth.
United Kingdom — 9.3% CAGR: Demand is shaped by protocol-driven care pathways and health technology assessments, with attention to cost-effectiveness and the management of chronic liver disease.
Germany — 9.1% CAGR: Specialist-led healthcare services and investment in advanced treatment technologies are supporting uptake, particularly in university hospitals and specialist gastroenterology and hepatology centres.
India and China are expected to record the fastest growth among the countries covered in the report. Their projected expansion contrasts with the more moderate, although still positive, growth expected in the UK and Germany.

What Leads the Market?

Automated systems, liver cirrhosis treatment and hospital-based care account for the leading shares of the market in 2026.

Automated paracentesis systems — 54.6%: The leading device-type segment, supported by controlled fluid removal, measured drainage and monitoring capabilities.
Liver cirrhosis — 64.1%: The leading treatment segment, reflecting the substantial need for ascites management among patients with advanced chronic liver disease.
Hospitals — 67.2%: The largest end-user segment, reflecting hospitals’ role in managing complex cases and performing fluid removal procedures.
Manual drainage kits and closed-loop systems serve additional procedural and care-setting requirements. Their future opportunities will depend on clinical suitability, affordability and the ability to meet the requirements of hospital, outpatient and home-care environments.

The Hurdle: Cost and Access

The cost of advanced automated systems and implantable pumps remains a major constraint. Fact.MR notes that higher equipment costs can limit adoption in price-sensitive healthcare systems and lower-resource settings, where basic manual drainage kits may remain more accessible.

For manufacturers, this creates a commercial challenge: demonstrating the economic value of advanced technologies while addressing differences in healthcare budgets, infrastructure and clinical capabilities. Evidence on total cost of care, complication rates and the requirements for home-based treatment will be relevant to purchasing and adoption decisions.

Industry Investment and Competitive Outlook

The market includes medical technology companies focused on fluid management alongside established suppliers of medical devices and procedural products. Fact.MR profiles the following companies:

Sequana Medical
Becton, Dickinson & Company (BD)
Cardinal Health
AngioDynamics
Cook Medical
Sequana Medical is identified in the report as a developer and commercializer of implantable pump systems. BD and Cardinal Health are discussed in connection with their distribution networks and procedural-kit portfolios.

The report highlights opportunities associated with simplified closed-loop systems, remote monitoring and technologies that support care beyond traditional hospital settings. However, the published report summary does not provide a dated list of recent company announcements or product launches. No specific investment announcement or partnership is therefore attributed to these companies in this release.

What This Means for Healthcare Procurement Teams and Device Manufacturers

1. Evaluate total cost of care, not only device prices. Procurement teams should compare acquisition costs with the wider costs of procedures, monitoring, repeat hospital visits and the resources required to manage patients. The report identifies cost as a significant adoption constraint but does not quantify savings for individual technologies.

2. Match device selection to the care setting. Hospitals account for 67.2% of the market, but outpatient and home-based care are emerging opportunities. Manufacturers should assess whether their systems meet the clinical, monitoring, training and operational requirements of the settings they intend to serve.

3. Prioritise market-specific access strategies. India and China offer the highest projected country growth rates, while the United States, United Kingdom and Germany have distinct healthcare purchasing and adoption dynamics. Suppliers should account for affordability, local infrastructure, reimbursement pathways and evidence requirements when planning market entry or expansion.

Unlock 360° insights for strategic decision making and investment planning:

Report Link

Fact.MR’s Ascites Fluid Removal Devices Market report covers market forecasts for 2026–2036, device types, treatment segments, end users, country-level growth and the competitive environment.

Explore More Related Studies Published by Fact.MR Research

Rhizoma Gastrodiae Tablets Market

Bioceramics Market

Critical Care Diagnostics Market

Radiation Proctitis Treatment Market

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.

Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: [email protected]
Phone: +1 (628) 251-1583
Website: www.factmr.com